Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at [email protected] Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Abbott India Hit With Rs 2.40 Cr GST Penalty Over Alleged ITC Disallowance, Plans Appeal

California judge allows Glucerna lawsuit against Abbott Labs to proceed

Written By Ruchika Sharma8 Jun 2024 10:30 AM IST

A California federal judge ruled on Wednesday that litigation against Abbott Laboratories alleging the marketing of Glucerna shakes and nutritional...

NPPA Finally Allows GSK to Discontinue Grisovin FP

GSK acquires Elsie Biotechnologies for up to USD 50 million

Written By Ruchika Sharma7 Jun 2024 4:22 PM IST

London: GSK plc has announced that it has acquired Elsie Biotechnologies, a San Diego-based private biotechnology company working on unlocking the...

Eli Lilly to Acquire Ajax Therapeutics in USD 2.3 Billion Cancer Drug Push

No major concerns raised by USFDA staff on Eli Lilly Alzheimer's drug Donanemab

Written By Ruchika Sharma7 Jun 2024 2:00 PM IST

London: FDA examination of trial data for Eli Lilly's investigational Alzheimer's drug Donanemab uncovered no red flags but did highlight safety...

Nestle India under SEBI net, gets warning letter

Nestle Health arm to buy global rights to VOWST

Written By Ruchika Sharma7 Jun 2024 12:30 PM IST

Seres Therapeutics, Inc., has announced that it has agreed to a non-binding memorandum of understanding with Nestle Health Science in which Nestle...

Indoco Remedies gets USFDA EIR for Patalganga facility

Indoco Remedies bags USFDA tentative nod for Canagliflozin and Metformin Hydrochloride Tablets for type 2 diabetes mellitus

Written By Ruchika Sharma6 Jun 2024 4:57 PM IST

Mumbai: Indoco Remedies Ltd. has announced the receipt of tentative approval from the U.S. Food and Drug Administration (USFDA) for Abbreviated...

Syngene International, Bristol Myers Squibb Extend Strategic Collaboration Through 2035

Syngene unveils platform for rapid, enhanced protein production

Written By Ruchika Sharma6 Jun 2024 1:30 PM IST

San Diego: A global contract research, development and manufacturing organization (CRDMO), Syngene International Ltd., has announced...

DCGI nod to Orchid Pharma Antibiotic Drug Combination of Cefepime, Enmetazobactam (NCE)

Written By Ruchika Sharma6 Jun 2024 12:25 PM IST

New Delhi: Chennai-based Pharma Company, Orchid Pharma, has received Drugs Controller General of India (DCGI) approval for the manufacturing and...

Lupin Receives USFDA EIR with VAI Status for Goa Manufacturing Plant

Lupin buys two brands from Sanofi in Europe, Canada

Written By Ruchika Sharma5 Jun 2024 3:00 PM IST

Mumbai: Lupin Limited, a global pharma major, today announced that Lupin Atlantis Holdings SA, the Company's European hub...

Maharashtra Govt Seeks Rs 26.5 Crore for Track-and-Trace System

AstraZeneca Tagrisso, chemotherapy recommended for approval in EU by CHMP for EGFR-mutated advanced lung cancer

Written By Ruchika Sharma5 Jun 2024 2:00 PM IST

Cambridge: AstraZeneca's Tagrisso (osimertinib) with the addition of pemetrexed and platinum-based chemotherapy has been recommended for...

Palamur Biosciences Faces USFDA Warning for Multiple GLP Compliance Failures

JnJ submits application to USFDA for expansion of Pediatric indication for HIV-1 Therapy Prezcobix

Written By Ruchika Sharma5 Jun 2024 1:00 PM IST

Titusville: Johnson & Johnson has announced the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug...

Aurobindo Pharma arm to acquire 20% additional ownership in Luoxin Aurovitas for Rs 45 crore

AstraZeneca concludes acquisition of Fusion Pharma

Written By Ruchika Sharma5 Jun 2024 10:15 AM IST

Cambridge: AstraZeneca has announced the successful completion of the acquisition of Fusion Pharmaceuticals Inc., a clinical-stage...

Sun Pharma to Present ILUMYA, LEQSELVI, WINLEVI Data at AAD 2026, Showcases Dermatology Advances

Sun Pharma, Philogen seek EMA marketing nod for skin cancer treatment Nidlegy

Written By Ruchika Sharma4 Jun 2024 4:45 PM IST

Mumbai: Philogen S.p.A. and Sun Pharmaceutical Industries Limited have announced the submission of a Marketing Authorization Application (MAA)...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok